Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FERNANDO L PAGAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1881682029
CMS profile
130424
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$172,503.31

268 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 268 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FERNANDO L PAGAN

NPI 1881682029 · CMS profile ID 130424

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 268 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1881682029?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FERNANDO L PAGAN, NPI 1881682029, CMS profile ID 130424. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 268 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881682029?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). FERNANDO L PAGAN, NPI 1881682029, CMS profile ID 130424. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 268 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881682029?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
FERNANDO L PAGAN, NPI 1881682029, CMS profile ID 130424, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 268 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1881682029?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

268 matching records · $172,503.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 268 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 268.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ACADIA Pharmaceuticals Inc $1,190.8910/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700017031 CMS
ACADIA Pharmaceuticals Inc $363.6110/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700017033 CMS
ACADIA Pharmaceuticals Inc $201.7310/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700017035 CMS
ACADIA Pharmaceuticals Inc $7,500.0010/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700017037 CMS
ACADIA Pharmaceuticals Inc $16.2410/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700017039 CMS
ACADIA Pharmaceuticals Inc $14.4710/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700017041 CMS
Acorda Therapeutics, Inc $477.6010/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633502341 CMS
Teva Pharmaceuticals USA, Inc. $4.4210/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697736121 CMS
US WorldMeds, LLC $59.0010/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448847 CMS
US WorldMeds, LLC $45.5510/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448853 CMS
US WorldMeds, LLC $44.1110/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448857 CMS
US WorldMeds, LLC $59.5510/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448863 CMS
US WorldMeds, LLC $139.1110/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448867 CMS
US WorldMeds, LLC $1.0410/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448907 CMS
US WorldMeds, LLC $269.0010/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448911 CMS
US WorldMeds, LLC $40.2210/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448915 CMS
US WorldMeds, LLC $101.7710/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448919 CMS
US WorldMeds, LLC $89.0810/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448923 CMS
US WorldMeds, LLC $152.7910/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448927 CMS
US WorldMeds, LLC $73.4310/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448933 CMS
US WorldMeds, LLC $269.0010/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448941 CMS
US WorldMeds, LLC $40.2210/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448945 CMS
Teva Pharmaceuticals USA, Inc. $125.0010/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697868113 CMS
Teva Pharmaceuticals USA, Inc. $4.2010/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697734365 CMS
Ipsen Biopharmaceuticals, Inc $17.1109/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 640638971 CMS
Medtronic USA, Inc. $520.0009/26/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667536473 CMS
Teva Pharmaceuticals USA, Inc. $3.1909/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697849509 CMS
Acorda Therapeutics, Inc $6,300.0009/24/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633502333 CMS
Acorda Therapeutics, Inc $3,400.0009/24/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633502335 CMS
Acorda Therapeutics, Inc $18.5609/24/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633502337 CMS
Acorda Therapeutics, Inc $17.2809/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633502339 CMS
Medtronic USA, Inc. $260.0009/17/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667536469 CMS
Amneal Pharmaceuticals LLC $14.5909/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692321541 CMS
Avanir Pharmaceuticals, Inc. $12.7309/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653597801 CMS
US WorldMeds, LLC $5,500.0009/13/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448441 CMS
US WorldMeds, LLC $4,000.0009/13/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699448949 CMS
Teva Pharmaceuticals USA, Inc. $3.4909/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697729409 CMS
Allergan Inc. $19.7009/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670910775 CMS
Teva Pharmaceuticals USA, Inc. $3.5509/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697800837 CMS
Teva Pharmaceuticals USA, Inc. $3.7708/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697773141 CMS
AbbVie, Inc. $24.1108/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128791 CMS
AbbVie, Inc. $14.2908/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128793 CMS
AbbVie, Inc. $47.6208/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128799 CMS
AbbVie, Inc. $14.2908/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128801 CMS
AbbVie, Inc. $33.3308/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128803 CMS
AbbVie, Inc. $615.8108/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128807 CMS
AbbVie, Inc. $123.3808/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128795 CMS
AbbVie, Inc. $102.2208/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128797 CMS
AbbVie, Inc. $181.2608/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648128805 CMS
Teva Pharmaceuticals USA, Inc. $3.8108/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697806079 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $172,503.31 268
PY2020 $150,180.34 139
PY2021 $86,960.45 142
PY2022 $92,355.77 159
PY2023 $68,917.70 174
PY2024 $56,016.45 157
PY2025 $63,049.90 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $95,612.45 8
PY2025 Principal investigator $347,593.09 37
PY2024 Recipient $1,484.39 4
PY2024 Principal investigator $270,113.21 27
PY2023 Principal investigator $451,065.21 42
PY2022 Recipient $74,382.07 6
PY2022 Principal investigator $354,360.22 15
PY2021 Principal investigator $70,947.34 24
PY2020 Recipient $1,889.80 4
PY2020 Principal investigator $148,270.66 53
PY2019 Principal investigator $1,384,924.88 146

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

45 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $2,256.72 12/31/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
An Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure of ABBV-951 in Subjects With Advanced Parkinson s Disease No dispute reported 06/30/2026 1202532797
Recipient Amneal Pharmaceuticals LLC $2,700.00 12/18/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530834
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $3,080.00 12/11/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051230
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $1,000.00 12/11/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051232
Principal investigator 1 Medtronic, Inc. $1,334.00 12/04/2025 Non-covered Recipient Entity
Georgetown University
PSR-DBS No dispute reported 06/30/2026 1192312867
Principal investigator 1 H. Lundbeck A S $2,440.00 12/01/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765483
Principal investigator 1 H. Lundbeck A S $11,679.30 11/19/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765481
Recipient Amneal Pharmaceuticals LLC $4,980.00 10/23/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530829
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $8,091.30 10/23/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051228
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $6,250.00 10/16/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051220
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $2,000.00 10/16/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051222
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $6,100.00 10/16/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051224
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $13,000.00 10/16/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051226
Recipient Amneal Pharmaceuticals LLC $15,252.85 10/14/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530825
Recipient Amneal Pharmaceuticals LLC $1,700.00 10/09/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530821
Principal investigator 1 H. Lundbeck A S $2,440.00 10/01/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765476
Principal investigator 1 Medtronic, Inc. $1,500.00 09/30/2025 Non-covered Recipient Entity
Georgetown University
PSR-DBS No dispute reported 06/30/2026 1192312865
Principal investigator 1 H. Lundbeck A S $6,136.20 09/12/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765470
Principal investigator 1 ABBVIE INC. $1,400.00 09/04/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease No dispute reported 06/30/2026 1202508828
Recipient Amneal Pharmaceuticals LLC $22,926.70 09/04/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530813
Recipient Amneal Pharmaceuticals LLC $22,926.70 09/04/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530817
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $500.00 09/04/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051218
Principal investigator 1 Medtronic, Inc. $3,200.00 08/27/2025 Non-covered Recipient Entity
Georgetown University
PSR-DBS No dispute reported 06/30/2026 1192312863
Principal investigator 1 H. Lundbeck A S $2,760.00 08/06/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765466
Principal investigator 1 H. Lundbeck A S $15,691.50 08/01/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765462
Recipient Amneal Pharmaceuticals LLC $12,563.10 07/22/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530803
Recipient Amneal Pharmaceuticals LLC $12,563.10 07/22/2025 Covered Recipient Physician IPX203-401-23 No dispute reported 06/30/2026 1220530810
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $3,080.00 07/17/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051214
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $2,000.00 07/17/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051216
Principal investigator 1 Medtronic, Inc. $1,400.00 07/16/2025 Non-covered Recipient Entity
Georgetown University
PSR-DBS No dispute reported 06/30/2026 1192312861
Principal investigator 1 ABBVIE INC. $1,970.00 07/15/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease No dispute reported 06/30/2026 1202498238
Principal investigator 1 H. Lundbeck A S $33,667.20 07/04/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765459
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $889.00 07/01/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA) No dispute reported 06/30/2026 1244051234
Principal investigator 1 H. Lundbeck A S $10,590.00 06/13/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765454
Principal investigator 1 Genentech, Inc. $24,920.00 06/05/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY GEORGETOWN UNIV CLINICAL TRIALS
Ph2a of IZD334 in Parkinsons disease No dispute reported 06/30/2026 1211610494
Principal investigator 1 KYOWA KIRIN, INC. $51,849.37 06/05/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
ISTRADEFYLLINE EFFECT ON PARKINSONS DISEASE TREMOR, MOTOR SYMPTOMS AND NON-MOTOR SYMPTOMS No dispute reported 06/30/2026 1221806583
Principal investigator 1 Medtronic, Inc. $635.00 05/19/2025 Non-covered Recipient Entity
Georgetown University
PSR-DBS No dispute reported 06/30/2026 1192312859
Principal investigator 1 ABBVIE INC. $12,380.00 04/22/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease No dispute reported 06/30/2026 1202478341
Principal investigator 1 ABBVIE INC. $5,683.00 04/16/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease No dispute reported 06/30/2026 1202477028
Principal investigator 1 ABBVIE INC. $2,948.00 03/06/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
M20-098 - Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease No dispute reported 06/30/2026 1202458561
Principal investigator 1 Sage Therapeutics, LLC $22,350.00 03/06/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor No dispute reported 06/30/2026 1206580678
Principal investigator 1 H. Lundbeck A S $30,300.00 02/21/2025 Covered Recipient Teaching Hospital
GEORGETOWN UNIVERSITY HOSPITAL
LU AF28996 IN PARTICIPANTS WITH PARKINSON'S DISEASE (PD) No dispute reported 06/30/2026 1251765447
Principal investigator 1 Medtronic, Inc. $1,343.00 02/14/2025 Non-covered Recipient Entity
Georgetown University
PSR-DBS No dispute reported 06/30/2026 1192312857
Principal investigator 1 KYOWA KIRIN, INC. $14,950.00 02/07/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
ISTRADEFYLLINE EFFECT ON PARKINSONS DISEASE TREMOR, MOTOR SYMPTOMS AND NON-MOTOR SYMPTOMS No dispute reported 06/30/2026 1221800837
Principal investigator 1 Sage Therapeutics, LLC $35,779.50 01/23/2025 Non-covered Recipient Entity
GEORGETOWN UNIVERSITY
Study to Evaluate SAGE-324 in Participants With Essential Tremors No dispute reported 06/30/2026 1206580998